Health ❯ Healthcare

Drug Efficacy

Clinical Research Progression-Free Survival Weight Loss Drugs Weight Loss Treatments Comparative Effectiveness Statistical Significance Monoclonal Antibodies Patient Outcomes Statins Clinical Outcomes

Epcoritamab Added to R2 Yields Large Efficacy Gains in Relapsed Follicular Lymphoma

Newly released results detail a chemo-free, outpatient regimen poised to reset second-line care.

Roivant’s Brepocitinib Succeeds in 52-Week Dermatomyositis Phase 3 as Companies Target 2026 FDA Filing

Regeneron’s Garetosmab Slashes New Bone Lesions in FOP Phase 3, U.S. Filing Planned This Year

Sanofi’s Amlitelimab Meets Phase 3 Goals in Eczema as Shares Fall on Tepid Efficacy